Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07426172

Role of Elevated Lactate Levels on Lipid and Carbohydrate Metabolism.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Ricardo Mora · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate whether the elevated circulating lactate levels of individuals with metabolic syndrome are responsible for their reduced lipolysis and glucose tolerance. The investigators will conduct an intervention study in which blood lactate levels will be elevated via intravenous infusion of sodium lactate. State of the art metabolic assessment using stable isotopes and indirect calorimetry will be used to study alterations in fat and carbohydrate metabolism.

Detailed description

Individuals with metabolic syndrome and insulin resistance exhibit higher resting lactate concentrations than age-matched counterparts without metabolic disease. Recent studies suggest that lactate is not just a by-product of accelerated glycolysis but a signaling molecule that could even affect gene expression. However, the role of lactate in carbohydrate and fat metabolism at rest and during exercise remains incompletely described. In this study, the investigators will elevate blood lactate levels in metabolically healthy individuals to levels observed in individuals with metabolic syndrome while measuring fat and carbohydrate metabolism in a fasted state, during exercise, and in response to an oral glucose load (oral glucose tolerance test). 10 metabolically healthy (MH) and 10 metabolically impaired (MI) individuals matched for sex and physical activity will participate in the study. MH will undergo two trials: one with intravenous lactate infusion and the other with isovolumetric saline infusion. The MI group will undergo only the saline trial. Each trial consists of a 150 min basal period, an exercise period, followed by a 2-hour oral glucose tolerance test (OGTT). During the test, the investigators will: Measure insulin sensitivity during the OGTT (Matsuda Index). Measure fat and carbohydrate oxidation using indirect calorimetry. Use stable isotope infusion to measure glycerol and glucose turnover rates in plasma using \[1,1,2,3,3 2H\]-glycerol and \[6-6 2H\], \[U, 13C\] - glucose. Collect blood samples of relevant hormones, metabolites, and cytokines.

Conditions

Interventions

TypeNameDescription
OTHERhyperlactacidemiaRaise blood lactate in metabolically healthy individuals to the levels of individuals with metabolic syndrome
OTHERSaline (0.9%, sterile, for infusion)Saline infusion as a control treatment

Timeline

Start date
2026-01-20
Primary completion
2028-01-30
Completion
2028-09-30
First posted
2026-02-23
Last updated
2026-02-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT07426172. Inclusion in this directory is not an endorsement.